Viral Pneumonitis in a 3-Month-Old Infant

Overview

Common Causative Viruses

At 3 months, RSV is by far the dominant pathogen and should be the primary diagnostic consideration, especially from October to May in temperate climates. — Red Book 2021, Report of the Committee on Infectious Diseases

Clinical Features

• Rhinitis, nasal congestion, cough
• Low-grade or absent fever (fever may be minimal in young infants)

• Tachypnea (most sensitive sign)
• Increased work of breathing: subcostal/intercostal retractions, nasal flaring, grunting
• Wheeze and/or crackles on auscultation
• Hypoxia (SpO₂ <90%)

• Apnea (especially in preterm infants and those <3 months) — can occur even without prominent respiratory symptoms
• Lethargy, irritability, poor feeding
• Central cyanosis
• Severe retractions / grunting

Infection with RSV during the first few weeks of life may present with more general symptoms — lethargy, irritability, poor feeding — with minimal respiratory tract symptoms, but these infants are at risk of developing apnea. — Red Book 2021

Risk Factors for Severe Disease

• Prematurity (especially <29 weeks gestational age)
• Chronic lung disease of prematurity / bronchopulmonary dysplasia
• Hemodynamically significant congenital heart disease (especially with pulmonary hypertension)
• Immunodeficiency
• Neurologic/neuromuscular conditions
• Low birth weight, maternal smoking, lack of breastfeeding, household crowding

Diagnosis

• Clinical diagnosis is standard in outpatient bronchiolitis/viral pneumonitis — routine viral testing does not change management in outpatients.
• Nasopharyngeal swab RT-PCR (multiplex respiratory viral panel): preferred when etiology matters (e.g., hospitalized patients requiring cohorting, immunocompromised hosts).
• Rapid antigen tests (RSV DFA, chromatographic immunoassay) are reliable in infants due to high viral shedding.
• Chest X-ray: hyperinflation, peribronchial thickening, patchy atelectasis, perihilar infiltrates. Not routinely required for typical bronchiolitis but useful if diagnosis uncertain or child deteriorates.
• Blood cultures / CRP / CBC: if bacterial superinfection suspected (uncommon, <1% risk of bacteremia in typical viral LRTI).

Management

Supportive Care (mainstay)

• Hydration: oral feeds if tolerated; NG or IV fluids if respiratory distress impairs feeding
• Nasal suctioning: before feeds and as needed
• Supplemental oxygen: when SpO₂ persistently <90%; target 90–94%
• Positioning: semi-upright

Respiratory Support (for hospitalized/severe cases)

• High-flow nasal cannula (HFNC) or nasal CPAP for moderate-severe disease
• Heliox has limited evidence
• Mechanical ventilation if respiratory failure — consult PICU/pulmonology

Medications — what NOT to use

No available treatment shortens the course of bronchiolitis or hastens resolution of symptoms. Management is supportive. — Red Book 2021, p. 979–980

Criteria for Hospitalization

• SpO₂ <90–92% on room air
• Significant work of breathing / grunting
• Apnea episodes
• Unable to maintain oral hydration
• Age <3 months (inherently higher risk; this patient)
• Premature birth history or high-risk comorbidities
• Parental concern / inability to monitor at home

Prevention

• IM injection 15 mg/kg once monthly during RSV season
• Indicated for high-risk infants (prematurity <29 weeks, CLD of prematurity, hemodynamically significant CHD, certain immunodeficiencies)
• Not a treatment — prophylaxis only
• Not cost-effective for all infants; reserved for highest-risk groups

Differential Diagnosis (to consider)

• Bacterial pneumonia (Group B Strep in neonates, S. pneumoniae, S. aureus — look for lobar consolidation, high fever, toxic appearance, elevated CRP/WBC)
• Chlamydia trachomatis pneumonia (afebrile pneumonia, staccato cough, eosinophilia — classically 3–16 weeks of age; treat with azithromycin)
• Pertussis (paroxysmal cough, inspiratory whoop, lymphocytosis)
• Congenital heart disease (ductal-dependent lesion presenting with respiratory distress)
• Aspiration pneumonitis

Key Points Summary

1. RSV is the most common cause of viral pneumonitis/bronchiolitis in a 3-month-old
2. Apnea is a specific danger in this age group — even without obvious respiratory signs
3. Management is entirely supportive — bronchodilators and steroids are not indicated
4. Hospitalization threshold is low at 3 months given the inherent risk
5. Antibiotics only if bacterial co-infection is confirmed
6. Palivizumab prophylaxis for high-risk infants; nirsevimab for broader prevention